Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neurol Sci ; 344(1-2): 20-6, 2014 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-24954089

RESUMEN

FK506 has been shown to exert neurotrophic and neuroprotective effects, but its long-term application for nerve regeneration is limited. This study evaluated the potential application of a novel FK506-loaded chitosan conduit for peripheral nerve repair, and explored the underlying mechanism. A sciatic nerve injury model was created in male Wistar rats, which were then randomly divided into three treatment groups (n=40, each): chitosan-only, chitosan+FK506 injection, and FK506-loaded chitosan. We found significant recovery of normal morphology of sciatic nerves and higher density of myelinated nerve fibers in rats treated with FK506-loaded chitosan. Similarly, the total number of myelinated nerve fibers, myelin sheath thickness, and axon diameters were significantly higher in this group compared with the others, and the compound muscle action potentials and motor nerve conduction velocity values of sciatic nerves were significantly higher. BDNF and TrkB levels in motor neurons were highest in rats treated with FK506-loaded chitosan. In conclusion, FK506-loaded chitosan promoted peripheral nerve repair and regeneration in a rat model of sciatic nerve injury. These effects are correlated with increased BDNF and TrkB expression in motor neurons.


Asunto(s)
Materiales Biocompatibles/uso terapéutico , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Quitosano/uso terapéutico , Inmunosupresores/uso terapéutico , Regeneración Nerviosa/efectos de los fármacos , Receptor trkB/metabolismo , Tacrolimus/uso terapéutico , Regulación hacia Arriba/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Combinación de Medicamentos , Estimulación Eléctrica , Potenciales Evocados/efectos de los fármacos , Potenciales Evocados/fisiología , Proteína GAP-43/metabolismo , Masculino , Conducción Nerviosa/efectos de los fármacos , Ratas , Ratas Wistar , Receptor trkB/genética , Neuropatía Ciática/tratamiento farmacológico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA